coopervision inc said has delayed its annual meeting june from may allow its board review possible recapitalization options before meeting coopervision today reported first quarter net income mln dlrs after 175 mln dlr pretax gain from sale its ophthalmic business johnson and johnson for 260 mln dlrs cash and mln dlr posttax charge from debt repurchase sales were mln dlrs year earlier earned 300 000 dlrs after 120 000 dlr loss from discontinued operations sales mln dlrs company said aggressive program investment spending maintain increase market shares its its two core businesses will accelerate sales growth this year but hold back increases operating income near future coopervision said furthermore until entire net cash proceeds from recent sales several businesses employed reduce indebtedness strategic acquisitions and otherwise employed relation possible recapitalization company recovery net income will held back loss particularly tax income ophthalmic pharmaceutical business sold johnson and johnson reuter 